NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port efficacy with microchip and sensor technology, NGP measures, monitors and reports physiological body functions in vivo over the course of disease and treatment.
In this episode, Founder and CEO Kathy Skinner shares the details of how this port advances care for a very important patient population and how its quickly gaining momentum.
AvodahMed is an advanced technology company improving quality care for patients and healthcare providers. They provide a unique solution that embeds AI throughout live...
ScriptChain is a digital health platform that sits on top of EHR systems and requests patient medical data from the EHR, runs through the...
Alex Stone is the Founder/CEO of Pacific Echelon Security Services, one of the fastest growing security companies in the United States. The company is...
